Breaking News Instant updates and real-time market news.

MRK

Merck

$62.77

0.11 (0.18%)

08:43
10/10/16
10/10
08:43
10/10/16
08:43

Merck 'steals the show' at ESMO with Keytruda data, says Leerink

Leerink analyst Seamus Fernandez said Merck (MRK) stole the show at ESMO with its Keytruda data and he continues to think the company will dominate first line lung cancer treatment for years to come in patients with 50%+ PDL1 expression. Additionally, he expects Merck to gain additional traction in the overall market, noting that confirmation that Keytruda is benefiting patients when combined with Alimta/carboplatin with Alimta maintenance raises the possibility Merck could compete broadly in the overall non-squamous patient population. However, Fernandez keeps a Market Perform rating on Merck, as he thinks its current valuation largely reflects improved growth prospects through 2020.

  • 25

    Oct

  • 06

    Nov

MRK Merck
$62.77

0.11 (0.18%)

10/10/16
BMOC
10/10/16
NO CHANGE
BMOC
Merck should strengthen leadership in first line NSCLC, says BMO Capital
BMO Capital analyst Alex Arfaei says that upcoming data should strengthen Merck's (MRK) lead in 1L NSCLC. The analyst adds that the data could support off-label use of Merck's Keytruda in additional 1L NSCLC patients, and he says that the data "should be negative" for Bristol-Myers' (BMY) Opdivo drug. Arfaei keeps an Outperform rating on Merck and a Market Perform rating on Bristol-Myers.
10/10/16
LEER
10/10/16
NO CHANGE
LEER
Outperform
Leerink sees Bristol-Myers sliding after Merck's 'spectacular' Keytruda data
Leerink analyst Seamus Fernandez said Bristol-Myers' (BMY) Checkmate-026 data presented at the European Society of Medical Oncology meeting was disappointing, noting there was no signal of benefit on progression-free survival or overall survival and only "modest differentiation" on response rate in the 88 patients with PDL1 biomarker positivity greater than or equal to 50%. Meanwhile, Merck (MRK) presented "spectacular" data for Keytruda monotherapy at the meeting, said Fernandez, who expects Bristol shares to be down "significantly" today in light of the meeting presentations. The analyst, who still thinks Bristol has a significant opportunity to compete with Merck's Keytruda in the PDL1 high portion of the market, keeps an Outperform rating on Bristol shares, which are down nearly 6% in pre-market trading.
10/07/16
LEER
10/07/16
NO CHANGE
LEER
Outperform
Incyte Epacadostat Phase 1 Melanoma data maturing well, says Leerink
Leerink analyst Michael Schmidt says the data from ECHO-202 Phase 1 study evaluating the combination of Incyte's (INCY) IDO1 inhibitor epacadostat with Merck's (MRK) Keytruda confirms the previously published results and appears to be maturing well. The analyst reiterates an Outperform rating on Incyte's shares, saying Jakafi remains a compelling long-term growth driver for the company, expectations for baricitinib are still moderate, and its maturing oncology pipeline of 14 molecules including epacadostat represents a long-term value driver.
10/03/16
LEER
10/03/16
NO CHANGE
LEER
Market Perform
AASLD abstracts hint at potential competitive threat to Gilead HCV, says Leerink
Leerink analyst Geoffrey Porges says abstracts for the American Association for the Study of Liver Diseases, or AASLD, meeting revealed very limited efficacy information about the new Hepatitis C regimens for Gilead (GILD), Merck (MRK) and AbbVie (ABBV). Nonetheless, the analyst believes the abstracts hint at the potential competitive threat to Gilead's HCV dominance. While the new 12-week HCV regimens may compete on price, the forthcoming 8-week regimens put the most pressure on Gilead's market share, Porges argues. He reiterates a Market Perform rating on Gilead's shares.

TODAY'S FREE FLY STORIES

HLX

Helix Energy

$7.41

-0.32 (-4.14%)

19:24
02/20/17
02/20
19:24
02/20/17
19:24
Earnings
Helix Energy reports Q4 EPS with items (46c), may not compare to consensus (6c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

CSII

Cardiovascular Systems

$29.19

0.76 (2.67%)

19:21
02/20/17
02/20
19:21
02/20/17
19:21
Hot Stocks
Cardiovascular Systems reports one-year data from COAST study »

Cardiovascular Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRMT

America's Car-Mart

$38.85

-1.15 (-2.88%)

19:17
02/20/17
02/20
19:17
02/20/17
19:17
Earnings
America's Car-Mart reports Q3 EPS 35c, may not compare to consensus 64c »

Reports Q3 revenue $139M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

ROG

Rogers Corporation

$78.80

-1.34 (-1.67%)

19:12
02/20/17
02/20
19:12
02/20/17
19:12
Earnings
Rogers Corporation sees Q1 adjusted EPS $1.09-$1.19, consensus 99c »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 01

    Mar

ROG

Rogers Corporation

$78.80

-1.34 (-1.67%)

19:11
02/20/17
02/20
19:11
02/20/17
19:11
Earnings
Rogers Corporation reports Q4 EPS 94c, consensus 82c »

Reports Q4 revenue $173M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 01

    Mar

HBHC

Hancock Holding

$46.80

-0.2 (-0.43%)

, FNBC

First NBC Bank

$4.75

-0.25 (-5.00%)

19:04
02/20/17
02/20
19:04
02/20/17
19:04
Hot Stocks
Hancock Holding says gets approval to close First NBC Bank transaction »

Hancock Holding (HBHC)…

HBHC

Hancock Holding

$46.80

-0.2 (-0.43%)

FNBC

First NBC Bank

$4.75

-0.25 (-5.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDSN

Nordson

$119.95

0.77 (0.65%)

19:03
02/20/17
02/20
19:03
02/20/17
19:03
Earnings
Nordson sees Q2 EPS $1.21-$1.33, consensus $1.22 »

Sees Q2 revenue up 3%-7%.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

NDSN

Nordson

$119.95

0.77 (0.65%)

19:01
02/20/17
02/20
19:01
02/20/17
19:01
Hot Stocks
Breaking Hot Stocks news story on Nordson »

Nordson says order rates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

NDSN

Nordson

$119.95

0.77 (0.65%)

19:00
02/20/17
02/20
19:00
02/20/17
19:00
Earnings
Nordson reports Q1 EPS 86c, consensus 82c »

Reports Q1 revenue $407M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

NDSN

Nordson

$119.95

0.77 (0.65%)

18:57
02/20/17
02/20
18:57
02/20/17
18:57
Hot Stocks
Nordson to acquire Vention AT for $705M »

Nordson announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

CYH

Community Health

$6.90

-0.22 (-3.09%)

18:55
02/20/17
02/20
18:55
02/20/17
18:55
Earnings
Community Health sees FY17 cont ops EPS 30c-$1.10 »

EPS consensus 61c. Sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 21

    Mar

CYH

Community Health

$6.90

-0.22 (-3.09%)

18:51
02/20/17
02/20
18:51
02/20/17
18:51
Earnings
Community Health reports Q4 adjusted EPS 46c, may not compare to consensus 13c »

Reports Q4 net operating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 21

    Mar

HSIC

Henry Schein

$168.11

0.86 (0.51%)

18:47
02/20/17
02/20
18:47
02/20/17
18:47
Hot Stocks
Henry Schein to acquire Southern Anesthesia + Surgical »

Henry Schein announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Feb

  • 24

    Feb

UIHC

United Insurance

$15.95

0.01 (0.06%)

18:45
02/20/17
02/20
18:45
02/20/17
18:45
Earnings
United Insurance reports Q4 EPS (49c), consensus (39c) »

Reports Q4 revenue $131M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 20

    Mar

VIPS

Vipshop

$12.16

-0.13 (-1.06%)

18:40
02/20/17
02/20
18:40
02/20/17
18:40
Earnings
Breaking Earnings news story on Vipshop »

Vipshop sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

VIPS

Vipshop

$12.16

-0.13 (-1.06%)

18:39
02/20/17
02/20
18:39
02/20/17
18:39
Earnings
Vipshop reports Q4 adjusted income per ADS 23c, consensus 21c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

WFC

Wells Fargo

$58.09

-0.03 (-0.05%)

, BK

BNY Mellon

$47.14

0.07 (0.15%)

18:36
02/20/17
02/20
18:36
02/20/17
18:36
Hot Stocks
Wells Fargo names two new independent directors »

The board of Wells Fargo…

WFC

Wells Fargo

$58.09

-0.03 (-0.05%)

BK

BNY Mellon

$47.14

0.07 (0.15%)

SPLS

Staples

$9.31

0.04 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 13

    Apr

  • 13

    Jul

  • 12

    Oct

  • 15

    Jan

BIOA

BioAmber

$3.66

-0.07 (-1.88%)

18:33
02/20/17
02/20
18:33
02/20/17
18:33
Hot Stocks
BioAmber says CEO Huc resigns, COO Orecchioni appointed president »

BioAmber announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBB

Cincinnati Bell

$19.85

-0.65 (-3.17%)

18:31
02/20/17
02/20
18:31
02/20/17
18:31
Hot Stocks
Cincinnati Bell subsidiary acquires SunTel Services »

CBTS, a wholly-owned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

VZ

Verizon

$49.19

0.73 (1.51%)

, AAPL

Apple

$135.72

0.375 (0.28%)

18:23
02/20/17
02/20
18:23
02/20/17
18:23
Hot Stocks
Verizon appoints Apple's Andrew McKechnie as creative chief of in-house agency »

Verizon (VZ) announced…

VZ

Verizon

$49.19

0.73 (1.51%)

AAPL

Apple

$135.72

0.375 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

  • 13

    Mar

NEE

NextEra Energy

$126.86

0.67 (0.53%)

18:19
02/20/17
02/20
18:19
02/20/17
18:19
Hot Stocks
NextEra Energy subsidiary says expands solar energy projects »

NextEra Energy subsidiary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

SNX

SYNNEX

$118.37

-0.23 (-0.19%)

18:14
02/20/17
02/20
18:14
02/20/17
18:14
Hot Stocks
Raritan announces distribution agreement with SYNNEX »

Raritan, a provider of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCX

Freeport McMoRan

$14.91

-0.16 (-1.06%)

18:06
02/20/17
02/20
18:06
02/20/17
18:06
Hot Stocks
Freeport McMoRan says fails to reach deal with Indonesia, sees Q1 sales impact »

Freeport McMoRan issued…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

WEN

Wendy's

$14.13

0.44 (3.21%)

18:01
02/20/17
02/20
18:01
02/20/17
18:01
Hot Stocks
Delight Restaurant Group acquires 30 Wendy's restaurants »

Delight Restaurant Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

CMG

Chipotle

$427.61

2.85 (0.67%)

17:59
02/20/17
02/20
17:59
02/20/17
17:59
Hot Stocks
Chipotle says 'Smarter Pickup Times' technology rolled out across U.S. »

Chipotle announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.